These results support the notion that TF and PS exposure is a general phenomenon seen for cancer cell-mediated coagulation in vitro, and support a role for CTC-mediated coagulation as a potential contributor to the hypercoagulability seen for patients with cancer. The gene discussed is TF; the disease is cancer.